Thomas Huber

Thomas Huber

Company: Almirall

Job title: Research Director

Seminars:

Panel Discussion: Debating the Mode of Delivery of Dermatological Therapeutics: Topicals vs Orals vs Injectables 5:15 pm

Should we be pursuing oral and injectable treatments when so many systemic side effects exist? – How do we reduce off-target effects? Is there merit in combinational therapy? How do we deliver this to patients? Can we administer topical treatments for severe disease? How do we monitor offsite JAK activity in topical treatments? Which dermatological…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.